Gene · 3197
Papers3,264
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,264
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Vitamin A, D, E, and K as Matrix Metalloproteinase-2/9 Regulators That Affect Expression and Enzymatic Activity. | Int J Mol Sci | 2023 | 38069361 | PubTator, text mining | PubMed |
| Liquid Biopsy in Alzheimer's Disease Patients Reveals Epigenetic Changes in the PRLHR Gene. | Cells | 2023 | 38067107 | PubTator, text mining | PubMed |
| Epigenome-wide association studies of prenatal maternal mental health and infant epigenetic profiles: a systematic review. | Transl Psychiatry | 2023 | 38062042 | PubTator, text mining | PubMed |
| Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemia. | Mol Cancer | 2023 | 38049829 | PubTator, text mining | PubMed |
| Associations between epigenome-wide DNA methylation and height-related traits among Sub-Saharan Africans: the RODAM study. | J Dev Orig Health Dis | 2023 | 38044700 | PubTator, text mining | PubMed |
| Unveiling the molecular structure and role of RBBP4/7: implications for epigenetic regulation and cancer research. | Front Mol Biosci | 2023 | 38028543 | PubTator, text mining | PubMed |
| Enhancers dysfunction in the 3D genome of cancer cells. | Front Cell Dev Biol | 2023 | 38020908 | PubTator, text mining | PubMed |
| Systematic characterization of the HOXA9 downstream targets in MLL-r leukemia by noncoding CRISPR screens. | Nat Commun | 2023 | 38016946 | PubTator, text mining | PubMed |
| METTL3-mediated HOTAIRM1 promotes vasculogenic mimicry icontributionsn glioma via regulating IGFBP2 expression. | J Transl Med | 2023 | 38012763 | PubTator, text mining | PubMed |
| Dependency of B-Cell Acute Lymphoblastic Leukemia and Multiple Myeloma Cell Lines on MEN1 Extends beyond MEN1-KMT2A Interaction. | Int J Mol Sci | 2023 | 38003662 | PubTator, text mining | PubMed |
| Non-Coding RNAs as Potential Targets for Diagnosis and Treatment of Oral Lichen Planus: A Narrative Review. | Biomolecules | 2023 | 38002328 | PubTator, text mining | PubMed |
| LncRNAs and CircRNAs as Strategies against Pathological Conditions Caused by a Hypoxic/Anoxic State. | Biomolecules | 2023 | 38002304 | PubTator, text mining | PubMed |
| An alternative NURF complex sustains acute myeloid leukemia by regulating the accessibility of insulator regions. | EMBO J | 2023 | 37987160 | PubTator, text mining | PubMed |
| Recent advances on high-efficiency of microRNAs in different types of lung cancer: a comprehensive review. | Cancer Cell Int | 2023 | 37986065 | PubTator, text mining | PubMed |
| Identification and targeting of treatment resistant progenitor populations in T-cell Acute Lymphoblastic Leukemia. | Res Sq | 2023 | 37961674 | PubTator, text mining | PubMed |
| AML under the Scope: Current Strategies and Treatment Involving FLT3 Inhibitors and Venetoclax-Based Regimens. | Int J Mol Sci | 2023 | 37958832 | PubTator, text mining | PubMed |
| Long Non-Coding RNA Signatures in the Ileum and Colon of Crohn's Disease Patients and Effect of Anti-TNF-α Treatment on Their Modulation. | Int J Mol Sci | 2023 | 37958675 | PubTator, text mining | PubMed |
| Nuclear transport proteins: structure, function, and disease relevance. | Signal Transduct Target Ther | 2023 | 37945593 | PubTator, text mining | PubMed |
| rs217727 of lncRNA H19 is Associated with Cervical Cancer Risk in the Chinese Han Population. | Pharmgenomics Pers Med | 2023 | 37928407 | PubTator, text mining | PubMed |
| SET-CAN/NUP214 fusion gene in leukemia: general features and clinical advances. | Front Oncol | 2023 | 37909026 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3197/papers?page=10